Noldoxen (Naloxone Hydrochloride, Oxycodone Hydrochloride)

Naloxone Hydrochloride and Oxycodone Hydrochloride, the active ingredients in Noldoxen, are a combined opioid antagonist/agonist presented as an oral tablet for oral use. It is employed to reverse opioid overdose while providing analgesia in controlled clinical settings.

GNH USA supplies Noldoxen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Noldoxen combines an opioid antagonist and agonist, acting on opioid pathways for acute overdose management and severe pain relief.

- Acute opioid overdose: rapidly reverses respiratory depression while allowing controlled analgesia. - Severe postoperative pain: provides effective analgesia for moderate to severe pain. - Chronic cancer pain: used under strict supervision for long‑term pain control.

Noldoxen may cause a range of adverse reactions related to both its naloxone and oxycodone components.

Common Side Effects: - Nausea: feeling of sickness or urge to vomit. - Constipation: reduced bowel movements. - Dizziness: light‑headed sensation. - Drowsiness: increased sleepiness. - Sweating: excessive perspiration. - Headache: mild to moderate head pain.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing. - Severe hypotension: marked drop in blood pressure. - Allergic reaction: rash, itching, swelling, or anaphylaxis. - Seizures: convulsive episodes. - Cardiac arrhythmia: irregular heart rhythm.

When prescribing Noldoxen, clinicians should consider several safety measures to minimize risk.

- Assess opioid tolerance: confirm patient’s prior exposure to opioids before initiating therapy. - Monitor respiratory function: observe breathing rate and oxygen saturation, especially after the first dose. - Evaluate hepatic and renal function: adjust use in patients with liver or kidney impairment. - Avoid use in patients with known hypersensitivity to naloxone or oxycodone. - Educate patients on signs of overdose and dependence. - Store at ambient temperature: keep below 25°C in the original packaging, protected from moisture.

Noldoxen can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Benzodiazepines: combined CNS depression may cause profound sedation and respiratory depression. - Alcohol: additive depressant effects increase risk of respiratory compromise. - Other opioids: additive opioid effects can lead to overdose. - MAO inhibitors: may potentiate opioid toxicity. - CNS depressants (e.g., barbiturates, antihistamines): heightened sedation and respiratory risk.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may increase oxycodone plasma levels. - CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce analgesic effect. - Antidepressants (e.g., SSRIs, SNRIs): monitor for serotonin syndrome. - Diuretics: may affect blood pressure when combined with hypotensive effects. - Anticholinergic agents: may exacerbate constipation.